VivoSeq
Other

Hygiene

0

Pipeline Programs↗

0

Active Trials↗

2

Companies Involved↗

Hygiene is an early-stage landscape with 0 programs across 2 companies. The most active players are Sanofi, GSK.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Unknown status3 · 43%

Clinical Trials

Trial Activity

7 trials

Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
Completed·Sanofi logoSanofi·Phase 3·NCT00380991·50 enrolled
Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene
Completed·Sanofi logoSanofi·Phase 3·NCT00371852·50 enrolled
Evaluation of Oral Hygiene Products in an In Situ Caries Model
Completed·GSK logoGSK·N/A·NCT02399163·80 enrolled
Evaluation of Two Hand Hygiene Products in ICUs
Completed·SSolventum US LLC·Phase 4·NCT02258412·51 enrolled
A Comparison of Three Different Modalities in Improving Oral Hygiene
Unknown status·—·Phase 4·NCT04386421·99 enrolled
Oral Hygiene Regimen in Patients on HCT
Unknown status·RRiyadh Colleges of Dentistry and Pharmacy·Phase 4·NCT02662374·45 enrolled
Effect of Ocular Hygiene on Scleral Lens Wear
Unknown status·UUniversity of Houston·Phase 1·NCT03544385·24 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)